Zenlabs Ethica Limited

Zenlabs Ethica Limited has entered into a business agreement with V Nexxtra Lifesciences Private Limited on 01-08-2026, appointing V Nexxtra Lifesciences Private Limited as its Sole and Exclusive Distributor. This disclosure is made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular dated 30th January 2026.

Key Agreement Details:

  • Parties: Zenlabs Ethica Limited and V Nexxtra Lifesciences Private Limited
  • Agreement Type: Domestic business agreement
  • Scope: V Nexxtra Lifesciences Private Limited is appointed as sole and exclusive distributor for the entire territory of India for the sale, marketing, promotion and distribution of the entire portfolio of products of Zenlabs Ethica Limited and its subsidiaries.

Responsibilities of V Nexxtra Lifesciences:

  • Responsible for marketing and promotion of Zenlabs Ethica Limited's products throughout India
  • Appointment and management of distributors, stockists and sales personnel
  • Sales planning, forecasting, market development, collection of orders and payments
  • Ensuring compliance with all applicable laws, rules, regulations relating to marketing, distribution and sale of products
  • Establishment and maintenance of depots, warehouses and distribution centers at its own cost
  • Bear all expenses relating to the sales team exclusively
  • Ensure compliance with pharmaceutical marketing, storage, transportation and distribution regulations
  • Not engage in similar marketing activities for any other company without mutual consent or approval from Zenlabs Ethica Limited

Financial Terms:

  • V Nexxtra Lifesciences shall pay Zenlabs Ethica Limited margin at the rate of 5% of the Net Sales Value (exclusive of GST)
  • Margin is payable on or before the 10th day of the succeeding month along with relevant sales/purchase statement
  • With effect from financial year 2027-28 onwards, margin shall be payable at 5.5% of Net Sales Value up to target turnover, reducing to 5% overall if target turnover is achieved
  • Credit period shall be up to seventy five (75) days from date of invoice unless otherwise agreed in writing
  • V Nexxtra guarantees minimum annual sales turnover and shall target turnover for each financial year as per respective Business Agreement
  • Minimum margin of 5% of the minimum turnover is payable

Additional Terms:

  • Zenlabs Ethica Limited shall supply products conforming to applicable quality standards and statutory requirements
  • V Nexxtra Lifesciences may identify and propose third-party manufacturing vendors, but final approval rests exclusively with Zenlabs Ethica Limited's quality assurance team
  • V Nexxtra must ensure not less than 70% of its total procurement (in value terms) is sourced from Zenlabs Ethica Limited group companies
  • All trademarks, brand names, logos, product registrations, copyrights and other intellectual property remain exclusive property of Zenlabs Ethica Limited
  • V Nexxtra Lifesciences shall not claim any ownership of intellectual property

Rationale and Expected Benefits:

The agreement aims to strengthen the Company's sales and distribution network, enhance market penetration, and improve customer reach through a dedicated distribution partner.